399 related articles for article (PubMed ID: 29165988)
1. Bioconjugate Strategies for the Induction of Antigen-Specific Tolerance in Autoimmune Diseases.
Yu C; Xi J; Li M; An M; Liu H
Bioconjug Chem; 2018 Mar; 29(3):719-732. PubMed ID: 29165988
[TBL] [Abstract][Full Text] [Related]
2. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease.
Miller SD; Turley DM; Podojil JR
Nat Rev Immunol; 2007 Sep; 7(9):665-77. PubMed ID: 17690713
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease.
Zonneveld-Huijssoon E; Albani S; Prakken BJ; van Wijk F
Clin Exp Immunol; 2013 Jan; 171(1):20-9. PubMed ID: 23199319
[TBL] [Abstract][Full Text] [Related]
4. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance.
Maldonado RA; LaMothe RA; Ferrari JD; Zhang AH; Rossi RJ; Kolte PN; Griset AP; O'Neil C; Altreuter DH; Browning E; Johnston L; Farokhzad OC; Langer R; Scott DW; von Andrian UH; Kishimoto TK
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):E156-65. PubMed ID: 25548186
[TBL] [Abstract][Full Text] [Related]
5. Ternary complex therapy for autoimmune disease.
Fathman CG
Hosp Pract (1995); 1995 Aug; 30(8):57-8, 60-2, 64-5. PubMed ID: 7635912
[TBL] [Abstract][Full Text] [Related]
6. Immunological mechanisms involved in experimental peptide immunotherapy of T-cell-mediated diseases.
Wauben MH
Crit Rev Immunol; 2000; 20(6):451-69. PubMed ID: 11396681
[TBL] [Abstract][Full Text] [Related]
7. The Mechanism of Action of Antigen Processing Independent T Cell Epitopes Designed for Immunotherapy of Autoimmune Diseases.
Shepard ER; Wegner A; Hill EV; Burton BR; Aerts S; Schurgers E; Hoedemaekers B; Ng STH; Streeter HB; Jansson L; Wraith DC
Front Immunol; 2021; 12():654201. PubMed ID: 33936079
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance.
Kishimoto TK; Maldonado RA
Front Immunol; 2018; 9():230. PubMed ID: 29515571
[TBL] [Abstract][Full Text] [Related]
9. Antigen-Specific Tolerization and Targeted Delivery as Therapeutic Strategies for Autoimmune Diseases.
Shakya AK; Nandakumar KS
Trends Biotechnol; 2018 Jul; 36(7):686-699. PubMed ID: 29588069
[TBL] [Abstract][Full Text] [Related]
10. Induction of antigen-specific unresponsiveness with synthetic peptides: specific immunotherapy for treatment of allergic and autoimmune conditions.
Wraith DC
Int Arch Allergy Immunol; 1995 Dec; 108(4):355-9. PubMed ID: 7580308
[TBL] [Abstract][Full Text] [Related]
11. Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity.
Northrup L; Christopher MA; Sullivan BP; Berkland C
Adv Drug Deliv Rev; 2016 Mar; 98():86-98. PubMed ID: 26546466
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in autoimmune diseases.
Miller A; Hafler DA; Weiner HL
Curr Opin Immunol; 1991 Dec; 3(6):936-40. PubMed ID: 1793539
[TBL] [Abstract][Full Text] [Related]
13. [The current outlook in the therapy of autoimmune diseases].
Sebastiani GD; Passiu G
Ann Ital Med Int; 1992; 7(2):95-101. PubMed ID: 1467130
[TBL] [Abstract][Full Text] [Related]
14. Induction of Oral Tolerance with Transgenic Plants Expressing Antigens for Prevention/Treatment of Autoimmune, Allergic and Inflammatory Diseases.
Ma S; Liao YC; Jevnikar AM
Curr Pharm Biotechnol; 2015; 16(11):1002-11. PubMed ID: 26306744
[TBL] [Abstract][Full Text] [Related]
15. Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases.
Sauer EL; Cloake NC; Greer JM
Int Rev Immunol; 2015; 34(6):460-85. PubMed ID: 25970132
[TBL] [Abstract][Full Text] [Related]
16. Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance.
Kuo R; Saito E; Miller SD; Shea LD
Mol Ther; 2017 Jul; 25(7):1676-1685. PubMed ID: 28408181
[TBL] [Abstract][Full Text] [Related]
17. Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine.
Bai XF; Link H
Clin Exp Allergy; 2000 Dec; 30(12):1688-96. PubMed ID: 11122206
[No Abstract] [Full Text] [Related]
18. Controlled Delivery of Single or Multiple Antigens in Tolerogenic Nanoparticles Using Peptide-Polymer Bioconjugates.
Pearson RM; Casey LM; Hughes KR; Wang LZ; North MG; Getts DR; Miller SD; Shea LD
Mol Ther; 2017 Jul; 25(7):1655-1664. PubMed ID: 28479234
[TBL] [Abstract][Full Text] [Related]
19. Systemic antigen in the treatment of T-cell-mediated autoimmune diseases.
Liblau R; Tisch R; Bercovici N; McDevitt HO
Immunol Today; 1997 Dec; 18(12):599-604. PubMed ID: 9425739
[TBL] [Abstract][Full Text] [Related]
20. Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy.
Verhagen J; Wegner A; Wraith DC
Immunology; 2015 Jun; 145(2):171-81. PubMed ID: 25716063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
